Sofidel America has decided to invest in Valmet’s Advantage DCT tissue line including an extensive automation package, flow control valves and Industrial Internet solutions to its Circleville mill in Ohio, United States. The target of the investment is to meet the American consumers’ increasing demand of high-quality tissue products with low environmental impact. The start-up is scheduled for the second half of 2025.
The order is included in Valmet’s orders received of the third quarter 2023. The value of the order will not be disclosed.
Valmet and Sofidel share a long history of partnership including eleven conventional tissue machines and four hybrid machines installed in various countries. The new Advantage DCT 200 (TM 3) line follows the two Valmet Advantage NTT lines installed at the Circleville mill in 2017.
“Sofidel has a strong focus on sustainable and high performing technologies that can fulfill our targets to increase capacity with as low environmental footprint as possible. The experience from recent Advantage ViscoNip rebuild projects has convinced us that it’s possible to achieve both energy savings and excellent paper properties under stable operating conditions. The industrial internet solutions will help us to further improve the performance,” says Simone Capuano, Executive VP, Operations and Supply chain, Sofidel America.
“We are proud to continue the journey together with Sofidel. The combination of Valmet’s Advantage DCT tissue machine, automation systems, flow control and Industrial Internet solutions is the most efficient production line on the market today. We will work closely together to meet the ambitious targets for the project,” says Johan Björn, Sales Director, Tissue Mills Business Unit, Paper Business Line, Valmet.
The new tissue line will have a design speed of 2,000 m/min and a width of 5,6 meters. The production line is optimized to save energy and deliver excellent paper properties. The line will have an annual production capacity of 70,000 tons.
Valmet’s scope of supply comprises a complete tissue production line including Advantage DCT 200 tissue machine with OptiFlo headbox and Yankee cylinder. It will also be featured with the Advantage tissue technology including ViscoNip press, AirCap hood with Air system, WetDust systems and a SoftReel reel. Valmet has also delivered detailed mill engineering, stock preparation equipment as well as automation, including Valmet DNA Distributed Control System (DCS) with built-in machine condition monitoring, Valmet IQ Quality Control System (QCS) and Web Monitoring System (WMS). The delivery also includes Valmet’s flow control and Industrial Internet solutions including Valmet Performance Center services, and Valmet Quality Predictor and Centerline Advisor applications.
www.valmet.com
